Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05854836 · ClinicalTrials.gov registry record · NA

Preconception Intervention for Incarcerated Women With Substance Use

A NA study of Substance Use Disorders, sponsored by St. Louis University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05854836: Recruiting NA study of Substance Use Disorders, sponsored by St. Louis University.

NCT05854836 is a NA study of Substance Use Disorders that is actively recruiting participants, run by St. Louis University. The registered enrollment target is 90 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05854836, a NA study of Substance Use Disorders, is actively recruiting participants, sponsored by St. Louis University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot trial is to test the feasibility and acceptability as well as efficacy of the adapted intervention, CHOICES-PLEAS (Pregnancy Liberated from Exposure to Alcohol and Substances) among women will illicit polysubstance use participating in a court-mandated jail-based 90-day substance use disorder treatment program. The main questions it aims to answer are: 1. What is the feasibility and acceptability of implementing the CHOICES-PLEAS intervention in a court-mandated jail-based substance use disorder treatment program? 2. Does participation in CHOICES-PLEAS lower the risk of a substance exposed pregnancy at 1 and 3 months after release compared to a control condition? 3. Does participation in CHOICES-PLEAS increase motivation to change substance use and reduce risky sexual behaviors at 1 and 3 months after release compared to a control condition? Participants will receive three one-on-one motivational interviewing sessions and one family planning referral visit during incarceration and one booster session at 1 month after release from jail. Researchers will compare the CHOICES-PLEAS intervention to a control condition to see if participation in the intervention reduces risk of substance exposed pregnancy, increases motivation to change substance use, and reduces risk of risky sexual behaviors.

Primary Outcome

Defined as continued drug abstinence, absence of risky sexual behaviors, or both

Conditions Studied

Interventions

  • BEHAVIORAL CHOICES-PLEAS (Pregnancy Liberated from Exposure to Alcohol and Substances)

Study Locations (1)

Missouri

  • Buzz Westfall Justice Center - St Louis

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-12-04
Est. Completion 2027-03-01
Phase NA
St. Louis University

107 total trials

What NCT05854836 shows while recruiting

NCT05854836 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which CHOICES-PLEAS (Pregnancy Liberated from Exposure to Alcohol and Substances) is the first listed.

NCT05854836 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05854836 about?

NCT05854836 is a clinical study titled "Preconception Intervention for Incarcerated Women With Substance Use". The goal of this pilot trial is to test the feasibility and acceptability as well as efficacy of the adapted intervention, CHOICES-PLEAS (Pregnancy Liberated from Exposure to Alcohol and Substances) among women will illicit polysubstance use participating in a court-mandated jail-based 90-day substa...

What is the current status of trial NCT05854836?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-12-04. Estimated completion is 2027-03-01.

What conditions does trial NCT05854836 study?

This clinical trial studies the following conditions: Substance Use Disorders.

What interventions are being tested in trial NCT05854836?

The interventions under investigation include: CHOICES-PLEAS (Pregnancy Liberated from Exposure to Alcohol and Substances) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05854836?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05854836 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05854836's enrollment target sits among peer trials

90 55th of 93 higher than 39 of 93 other Substance Use Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05854836, the US trial registry maintained by the National Library of Medicine. NCT05854836 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.